Daily as of 3 Nov 16:00 ET
- Price
- between the two $72.64 vs 50 $75.17 / 200 $67.79
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 21 Sep 2026 · projected 28 bars out
TARS | Tarsus PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$72.64
-$0.68 (-0.93%)
Tarsus Pharmaceuticals (TARS) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.
The 50 SMA has sat above the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the weekly and the 4-hour, price sits above the 50 and the 200; on the daily it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $74.85 vs 50 $69.51 / 200 $42.33
- Projection
- No cross projected
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 13:30 ET
- Price
- above both $73.86 vs 50 $72.74 / 200 $69.32
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 21 Aug 2026 · projected 27 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 21 Sep 2026 | 🟨Golden steep | daily | 28 bars out | Not tested |
| 21 Aug 2026 | 🟨Golden | 4-hour | 27 bars out | Not tested |
| 14 May 2026 | 💀Death moderate | daily | 24 bars out | 2 bar cross test |
| 6 Feb 2026 | 💀Death | 4-hour | 30 bars out | Not tested |
| 11 Sep 2025 | 🟨Golden steep | daily | 29 bars out | 2 bar cross test |
About TARS
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$49.9M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandmid